The Prevalence Of Metabolic Syndrome In Older People: “Attitude Towards Population Success”

Aronov D.M. Physical training programs for the prevention of cardiovascular complications in apparently healthy people with various risk factors for coronary artery disease. Methodical recommendations // Preventive medicine.-2014.-17(3):63-65.

Belenkov Yu.N., Chazova I.E., Mychki V.B. Multicenter randomized open-label study to study the effectiveness of lifestyle changes and therapy with ACE inhibitors (quinapril) in patients with obesity and arterial hypertension (IVF) // Art. hypert. 2003; 9(6): 196-8.

Boytsov S.A., Chuchalina A.G. Prevention of chronic non-communicable diseases. A practical guide. M.: GNITsPM.-2013.

Bokarev I.N., Dunin P.A., Ovchinnikov Yu.V. Arterial hypertension: current state of the problem // Clinical medicine.-2017-Vol. 95.-№7-P.581-585.

Bganyan R.A., Kalinina A.M., Karamnova N.S., Ipatov P.V. et al. Methodological aspects of identifying and correcting alimentary-dependent risk factors for cardiovascular diseases in the course of clinical examination of certain groups of the adult population of Russia // Preventive Medicine.-2015.-№1.-P.3.

Verbovoy A.F., Pashentseva A.V., Sharapova L.L. Obesity and the cardiovascular system // Clinical medicine -2017.-95 (1).-№1.-P.31-34.

Gruzdeva O.V., Palicheva E.I., Maksimov S.A. et al. Metabolic risk factors for the development of diseases of the circulatory system in different age groups // Clinical recommendation:-2017.- Vol 95.-№11.-P.1035-1040.

Kobyakova O.S., Kulikov E.S., Deev I.A., Almikeeva A.A., et al. The frequency of risk factors for chronic non-infectious diseases among doctors in the Russian Federation on the model of the Tomsk region // Cardiovascular therapy and prevention.-2018:17(6).-P.-44-50.

Karpov Yu.A., Shubina A.T. Reducing the risk of complications in metabolic syndrome: the role of a fixed combination of losartan and amlodipine // Atmosphere. Cardiology news. -2016.-№3.-P. 29-34.

Cardiology. National leadership. 2nd edition, revised and enlarged // Edited by Academician E.V. Shlyakhto.-Moscow.-2019-P.391.

Casio Tushita. Measures to prevent visceral obesity and cardiovascular risk factors: the essence and results of a lifestyle change program aimed at combating metabolic syndrome in Japan // VII International Internet Congress of Specialists in Internal Medicine. - Moscow.-VIDOX -2018.-P.9-10.

Korneeva O.N., Drapkina O.M., Ivashkin V.T. Clinical variants of metabolic syndrome -2007.

Mamedov M.N. Metabolic syndrome in Russia: prevalence, clinical features and treatment. Moscow: News of the Administrative Department of the President of the Russian Federation. -2011.

Mohort T.V., Mohort E.G. Cognitive impairments and diabetes mellitus: prevention and treatment options // Health of Uzbekistan. -2016-№(04)-P.66-67.

Ochanov R.G., Kalinina A.M., Pozdnyakov Yu.M. Preventive cardiology. -Moscow -2003.-P.33-36.

The first results of the Russian program "April" (The effectiveness of the use of acarbose in patients with impaired glucose tolerance and arterial hypertension // Obese metabolic 2005; 1(3): 13-1.

Popov V.V., Novikova I.A., Prokhova M.V., Litvyakova M.L. and others. Early diagnosis and prevention of age-associated disorders in elderly and senile people living in the European North of Russia // Preventive Medicine.-2019-№3-P.77.

Prevention of chronic non-communicable diseases. Russian recommendations // Ed. Boitsova S.A.-Moscow -2013-P.75-76.

Strazheeko I.D., Akasheva D.U., Dudinskaya E.N., Tkacheva O.N. Aging of blood vessels: main signs and mechanisms // Cardiovascular therapy and prevention -2012; 11(4): 95-99.

Shubina A.L., Demidova I.Yu., Karpov Yu.A. metabolic syndrome X: prerequisites for the development of arterial hypertension and atherosclerosis // Clinical Pharmacology and Therapy.-2001;10(4):45-46.

Shapiro I.A. Secondary prevention of cardiovascular diseases at the level of outpatient clinics in the context of health care reforms // Author. doct. diss.-M.-2002.

Degtyarev V.A. On the question of determining blood pressure by auscultatory method // Functional diagnostics -2007;(2): 6-10.

Diagnosis and treatment of metabolic syndrome. Russian recommendations. –Moscow // Appendix 2 to the journal "Cardiovascular Therapy and Prevention" 6/6.-P.4-5.

Drapkina O.M. Metabolic syndrome: cardiovascular and gastroenterological comorbidity // III International Internet Congress of Specialists in Internal Medicine - Moscow.VIDOX-2018.

Chazova I.E., Mychka V.B. Metabolic syndrome. М:Media Medica.2004-P.48-49.

Chazova I.E., Mychka V.B. Multicenter, randomized, scientific and practical program MINOTAVR: intermediate analysis of the results // Kardiovask. ter. profile 2006; 2:81-6.

Alwan A. The World Report of Non communicable Diseases // WHO library Cataloguingin Publication Data: General, 2013- P. 161.

Bykov A.T. , Malyarenko T.N. , Dynrhykov A.A. et al. About efficacy of the training exercises in rehabilitation of the patients undergoing surgical myocardial revascularization // Medical Bulleten of the South of Russia.-2012; 3:7-15.

Borch – Sohnsen K., Wareham N. The risk and fall of the metabolic syndrome // Diabetalogia. -2010;53(4):597-598

https://www.who.int/Features/Fartfiles/ageing/ru/index.html.

Franklin S.S. Do Diabetes and hypertension interact to accelerate vascular ageing? // J Jlypertens 2002 ; 20(9) : 1699-1664.

Gandhi H.K., Vaishali V., frem R. et al A survecy on physical activity and noncommunicable diseacal risk factors among physicians in terriary care hos pitals, Mangalor. //Nat J Commun Med.2012; 3(1):7-12.

Hanefeld M., Pistrosh F., Schulze J.et al. The metabolic syndrome and cardiovascular diseases: an update of medical theatment //J Metabolic Synd 2014; 3(4): 160-165.

European Society of Hypertension – European Society Cardiology Guidelines for the management of arterial hypertension // J Hypertens-2003; 21:1011-52.

Kynene Sh, Taukobong NP. Dietary habits among health professionals working in a district hospital in Kwazulu-Natal, South Africa // Afr J prim Health Care Fam Med. 2017;9(1): 1364.doi:10.4102/phefm. V9:1.1364.

Mazzali M., Kanellis J., Han L. et al. Hyperuricemia induces a primary renal arteberiolopathy in rats 64-nism // Am J Physial Renal Physial .2002;282:f 991-

Milions H., KaKafika A. Effects of Statin Treatment on Uric Acid Homeostasis in Patients with Primary Hyperlipidemia //Am Hearth J 2004; 148 (4):636-39.

Nillson P.M. Hemodynamic aging as the coseguence of structural changes associated with Early Vascular Aging (EVA) //Aying Dis 2014; 5(2):110-112.

Nilsson P.M., Lurbe E., Lanrent S. Thelarly life oriyns of vascular ageing and cardiovascular ageing risk: the EVA syndrome //Hypertens 2008; 26(6):1049-1055.

Makladalona M., Sovova E., Ivanova K. et al Risk Factors For cardiovascular diseases in physicians //J.Blomed.Pap.Med.Fac.Univ.

Oganov R.G., Maslennikova C.V., Tyurina T.V. et al. How to help smoking patients : new opportunities // Кардиоваскулярная терапияю -2011-10(5). –С.4-6.

Paulweber B., Valensi P., Kindsfrom J. European Evidense-Based Guideline for the Prevention of Type 2 Diabetes // Horm and Metab Research 2010 ; 42(suppl.1) : 3-31.

Seobodyyanyuk A.L., Krylova J.A., Kyraev V.I. Primary care : now to increase physical activity in your patients // Archives of Internal Medicine -2019;9(4) : 269-279. Doi : 10-20514 / 2226-6704-2019.9-4-269-279.

Standatr FC, Durkin MN,Blair SN. Determining levels of physical activity in attending physicians , resident and fellow Physicians and fellow physicians and medi physicians resident and fellow physicians and medical students in the USA // Br J Sports Med . -20102; 46(5) : 360.4. doi : 10.1136//bisports -2011-090299.

Verdecchial P., Schillaci G., Reboldi G. et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension // The PIUMA study. Hypertension 200; 36 : 1073-8.

Ryden L., Grant P.I., Ankon S.D., BerneC., Cosentino F., Danchin N. et al. ESC Guidelineson diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD : The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European society of Cardiology (ESC) and developed in collaboration with the European Association for the dtudy of Diabetes [EASD] // Eur Heart J 2013; 34 (39) : 3035-3085.

World Health Statistics 2014. World Health Organization.

Zimmed P., Shaw J., Alberti G. Preventing type 2 diabetes and the dysmetobolic syndrome in the world : a realistic view. Diabetic medicine 2003; 20(9) : 693-701.